Skip to main content

Bronchoalveolar Lavage (BAL) and Pathologic Assessment of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): The EVALI-BAL Study, A Multicenter Cohort.

Publication ,  Journal Article
Harry-Hernandez, S; Thiboutot, J; Wahidi, MM; Giovacchini, CX; De Cardenas, J; Meldrum, C; Los, JG; Illei, PB; Shojaee, S; Eissenberg, T ...
Published in: J Bronchology Interv Pulmonol
April 1, 2023

BACKGROUND: E-cigarette or vaping-use related acute lung injury (EVALI) is a spectrum of radiographic and histologic patterns consistent with acute to subacute lung injury. However, limited data exist characterizing bronchoalveolar lavage (BAL) findings. The goal of this study is to further define the pathologic findings from BAL and biopsy samples of subjects with EVALI across 7 institutions. METHODS: A multicentered registry of patients admitted with EVALI who underwent flexible bronchoscopy with BAL+/-transbronchial biopsy from July 2019 to April 2021 was compiled for retrospective evaluation from 7 academic institutions throughout the United States. Radiographic and cytopathologic findings and frequencies were correlated with the substance vaped. RESULTS: Data from 21 subjects (42.9% women) who were predominantly White (76.2%) with a median age of 25 years (range, 16 to 68) with EVALI were included in this study. Sixteen patients (76.2%) reported use of tetrahydrocannabinol; the remainder used nicotine. BAL was performed in 19 of the 21 subjects, and transbronchial lung biopsy was performed in 7 subjects. BAL findings revealed neutrophilic predominance (median, 59.5%, range, 3.1 to 98) in most cases. Ten BAL samples demonstrated pulmonary eosinophilia ranging from 0.2% to 49.1% with one subject suggesting a diagnosis of acute eosinophilic pneumonia associated with the use of e-cigarettes. Lipid-laden macrophages were noted in 10 of 15 reports (66.7%). Transbronchial biopsy most frequently demonstrated patterns of organizing pneumonia (57.1%). CONCLUSION: EVALI-associated BAL findings typically demonstrate a spectrum of nonspecific inflammatory changes, including neutrophilia, lipid-laden macrophages, and in some cases eosinophilia.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Bronchology Interv Pulmonol

DOI

EISSN

1948-8270

Publication Date

April 1, 2023

Volume

30

Issue

2

Start / End Page

144 / 154

Location

United States

Related Subject Headings

  • Young Adult
  • United States
  • Retrospective Studies
  • Middle Aged
  • Male
  • Lung Injury
  • Lipids
  • Humans
  • Female
  • Electronic Nicotine Delivery Systems
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harry-Hernandez, S., Thiboutot, J., Wahidi, M. M., Giovacchini, C. X., De Cardenas, J., Meldrum, C., … Kapp, C. M. (2023). Bronchoalveolar Lavage (BAL) and Pathologic Assessment of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): The EVALI-BAL Study, A Multicenter Cohort. J Bronchology Interv Pulmonol, 30(2), 144–154. https://doi.org/10.1097/LBR.0000000000000890
Harry-Hernandez, Salem, Jeffrey Thiboutot, Momen M. Wahidi, Coral X. Giovacchini, Jose De Cardenas, Catherine Meldrum, Jenna G. Los, et al. “Bronchoalveolar Lavage (BAL) and Pathologic Assessment of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): The EVALI-BAL Study, A Multicenter Cohort.J Bronchology Interv Pulmonol 30, no. 2 (April 1, 2023): 144–54. https://doi.org/10.1097/LBR.0000000000000890.
Harry-Hernandez S, Thiboutot J, Wahidi MM, Giovacchini CX, De Cardenas J, Meldrum C, et al. Bronchoalveolar Lavage (BAL) and Pathologic Assessment of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): The EVALI-BAL Study, A Multicenter Cohort. J Bronchology Interv Pulmonol. 2023 Apr 1;30(2):144–54.
Harry-Hernandez, Salem, et al. “Bronchoalveolar Lavage (BAL) and Pathologic Assessment of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): The EVALI-BAL Study, A Multicenter Cohort.J Bronchology Interv Pulmonol, vol. 30, no. 2, Apr. 2023, pp. 144–54. Pubmed, doi:10.1097/LBR.0000000000000890.
Harry-Hernandez S, Thiboutot J, Wahidi MM, Giovacchini CX, De Cardenas J, Meldrum C, Los JG, Illei PB, Shojaee S, Eissenberg T, DiBardino D, Giannini H, Maldonado F, Roller L, Yarmus LB, Kapp CM. Bronchoalveolar Lavage (BAL) and Pathologic Assessment of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): The EVALI-BAL Study, A Multicenter Cohort. J Bronchology Interv Pulmonol. 2023 Apr 1;30(2):144–154.

Published In

J Bronchology Interv Pulmonol

DOI

EISSN

1948-8270

Publication Date

April 1, 2023

Volume

30

Issue

2

Start / End Page

144 / 154

Location

United States

Related Subject Headings

  • Young Adult
  • United States
  • Retrospective Studies
  • Middle Aged
  • Male
  • Lung Injury
  • Lipids
  • Humans
  • Female
  • Electronic Nicotine Delivery Systems